SciTech Development is a clinical-stage pharmaceutical oncology company that is advancing ST-001 nanoFenretinide™, patented, new cancer drug currently in clinical trials for T-cell non-Hodgkin lymphoma and upcoming small cell lung cancer trials. Seeking pharma partners and investors.
Address
Grosse Pointe FarmsMichigan
United States
